A team of four researchers, led by Professor Tomás Ryan, will explore how the brain stores memories of immune and sickness experiences to make predictions about future challenges. The project aims to determine the effect of chronic inflammation during pregnancy on immune memory function and its impact on altered neural development.
A study published in Advanced Science reveals that TREM2+ macrophages contribute to immune dysfunction in endometriosis, compromising CD8+ T cell and NK cell cytotoxic behavior. Researchers identified TREM2 as a potential therapeutic target, suggesting new avenues for developing non-hormonal therapies for endometriosis.
Recent advances in biomaterials and regenerative medicine enable precise regulation of the cardiac immune microenvironment to promote functional recovery after myocardial infarction. Targeted immunomodulatory strategies, including nanoparticle delivery systems and injectable hydrogels, show promise in reducing excessive inflammation an...
Researchers developed a combination therapy approach using TargetScore algorithm to target PARP and SHP2 proteins, overcoming treatment resistance in breast cancer models. This approach showed durable responses and improved survival in multiple preclinical models.
Researchers investigate how early inflammation and stress can lead to long-term changes in brain cells, making them more susceptible to Alzheimer's disease. Cellular
A new study reveals that the CASS4 gene plays a crucial role in Alzheimer's disease by directing brain-cleaning immune cells, which can be disrupted leading to the buildup of toxic plaques. This discovery offers new hope for the development of treatments or prevention strategies by targeting the gene or microglia in the brain.
Researchers at UC San Francisco found that a high-fat diet for just a few days can cause a significant immune response, even after returning to a low-fat diet. The study showed that rapid-response immune cells were activated, leaving the tissue primed for the next time, and that diet can have a rapid impact on immune health. The findin...
Lupus patients have mutated immune cells that may spark internal self-attack and tissue damage, a potential clue to the disease's driving cause. The mutated cells, called neutrophils, have unusual errors in their RNA code, leading to the production of
Researchers mapped 5 million individual immune cells from 2,000 people, identifying nearly 1,500 genes linked to a range of diseases. The findings provide a detailed map of how genetic variation shapes the immune system, enabling targeted treatments and precision medicine.
Researchers at the University of Southampton have created a type of killer cell that can recall how to fight off respiratory diseases, offering a potential new approach to protecting against flu, colds, and RSV. This innovative technique aims to enhance the body's natural defense system, providing long-lasting protection against viruses.
DS1025, a CD25-directed antibody drug conjugate, targets immunosuppressive regulatory T cells in the tumor microenvironment, aiming to reduce a mechanism that can limit the body's immune response against cancer. The trial is an international effort to investigate DS1025 in patients with advanced solid tumors.
A new study finds that prenatal nicotine exposure can lead to increased flu severity in adulthood, altering lung immune cells and blood stem cells. In mice models, nicotine exposure during pregnancy and shortly after birth impairs the development of these cells, making offspring more susceptible to respiratory infections.
UChicago Medicine launches a groundbreaking clinical trial testing a new personalized cell therapy for advanced solid tumors, including ovarian cancer and melanoma. The treatment uses specially engineered T-cell receptors to detect hidden cancer proteins, expanding the number of cancers that can be targeted.
The review highlights the importance of balancing mechanical support, biological activity and controlled degradation in bone regeneration. Silk fibroin-PLA composite scaffolds have shown improved cell responses, osteogenic activity, mechanical performance and tissue repair in experimental models.
Dr. Annet Kirabo's research revealed how immune activation and inflammation contribute to high blood pressure, identifying potential therapeutic targets for preventing and treating hypertension. Her work has reshaped the understanding of cardiovascular disease, opening exciting possibilities for new treatments.
Researchers identified a previously unknown pathway that prostate tumors leverage to suppress the immune system, reshaping the tumor microenvironment to resist treatment. Combining B7-H3-targeted therapy with MEK inhibition improved antitumor responses and prolonged survival in preclinical models of castration-resistant prostate cancer.
The new guidelines, developed by leading experts, focus on improving sepsis care by strengthening systems for diagnosis, treatment, prevention, and quality improvement. Emerging technologies, such as next-generation diagnostics and artificial intelligence, are also being explored to enhance sepsis care.
Researchers have developed a computational framework to design and fabricate crisscross DNA megastructures, expanding accessibility to DNA nanotechnology. This breakthrough enables the construction of complex structures with precise control, opening up new avenues for applications in fields like optics, immunology, and tissue engineering.
Researchers develop nanoparticles that target tumor-associated macrophages, reprogramming them to attract cancer-fighting T cells. The approach shows promise in reducing immune-suppressing macrophages and increasing cancer-fighting T cells, with potential for improving immunotherapy for solid cancers.
Researchers found that rituximab treatment increases mitochondrial energy production and reduces cell stress in T cells, leading to improved response rates in patients with nephrotic syndrome. This discovery could help predict patient response to treatment and identify suitable candidates for early remission.
Researchers have developed a nondestructive imaging technique to measure single-cell immune metabolism in real patient blood samples, providing a higher level of information than current clinical techniques. This breakthrough could improve disease diagnosis and treatment for conditions like blood cancers, lupus, and sepsis.
Researchers at La Jolla Institute for Immunology have developed a vaccine that uses T cells to fight Zika virus, but one vaccine, with both antibody and T cell protection, showed long-term protection against the virus. This discovery offers a new hope in the fight against Zika and its close viral relatives.
Researchers found that longer-lived bats have higher levels of cancer-fighting genes and an immune system that can mount an overwhelming attack against infectious organisms and cancer. This discovery suggests that understanding one will help scientists understand the other.
UCSF scientists have invented a way to treat cancer with teacher cells and tumor pieces, combining immune cells grown in the lab with patient tumor samples. The method uses dendritic cells to train T cells to recognize and destroy cancer cells, offering a promising approach to immunotherapy.
Researchers found that radiation to the thymus during NSCLC treatment increased cancer spread and mortality risk in patients with relatively healthy thymus. Thymic health scores were associated with T-cell diversity, longevity, and cancer outcomes.
A new study has discovered a molecular navigation system that precisely directs neutrophils to sites of infection, allowing them to fight off disease-causing microbes without damaging healthy tissue. This finding represents a promising therapeutic strategy for treating chronic inflammatory diseases.
Scientists have identified multiple targets for antibodies that could treat Crimean-Congo hemorrhagic fever, a deadly virus spread by ticks. The research found that antibodies targeting the nucleocapsid protein offer protection against the virus, regardless of strain, and could lead to the development of new treatments.
A new study from Arizona State University finds that past immune encounters can predict future vaccine response, opening a path toward more personalized vaccination strategies. Researchers analyzed blood samples from over 4,000 people, identifying antibody signatures that distinguish strong responders from weak ones.
Researchers at Pusan National University investigated how chronic environmental stress drives immune dysfunction in cold tumors, revealing a key driver of NK-cell maladaptation: the GDF15-AhR axis. This axis sustains activation of stress-sensing receptors, gradually exhausting NK cells and enabling immune escape.
Researchers discover a subset of clear cell ovarian cancers responsive to immunotherapy, driven by inflammation-related protein IL-17. IL-17 acts directly on cancer cells, creating an immune-permissive tumor microenvironment, enabling prediction of treatment response and contributing to personalized medicine.
Scientists create a biomimetic zona pellucida coating called BZP to mimic the natural barrier on egg cells, protecting donor islets from the immune system and reducing blood sugar levels in diabetic mice for 100 days. This approach could lead to a promising commercial cell therapy platform for treating various diseases.
Researchers have discovered that proteins released from mitochondria can activate the immune system in a similar way to invading bacteria. Elevated levels of mitochondrial proteins were found circulating in the bloodstream even when no live bacteria were present, leading to excessive inflammation.
Researchers at UCLA Health Jonsson Comprehensive Cancer Center are developing drug-based strategies to enhance cancer immunotherapy for melanoma and potentially other cancers. They identified two promising compounds that could strengthen T cell interaction with cancer cells or make tumor cells more susceptible to destruction by T cells.
A team of LMU researchers identified a signaling pathway in mice through which dietary changes influence the development of the immune system. The study found that dendritic cells are activated by dietary signals, which shape how T cells respond to environmental substances.
Researchers at La Jolla Institute for Immunology discovered that immune cells in lung tissue express genes associated with autoimmune disease risk. These tissue-resident immune cells may actively drive the development of autoimmune diseases, particularly in women.
The Alliance QUANTUM trial is testing whether post-transplant consolidation therapy with teclistamab improves survival in patients with primary plasma cell leukemia. Plasma cell leukemia is a rare but aggressive blood cancer with poor long-term survival rates.
Researchers at Tulane University discovered that vesper bats have two distinct copies of genes producing antibodies, which helps them recognize and fight infections. This finding opens up new areas of study on the evolution of immunity and how animals respond to diseases.
A recent study found that human lung tissue contains a vast reservoir of tissue-resident memory T cells (T RM cells) capable of targeting a range of viruses, bacteria, and fungi. These cells reside only in the lungs and can live for years, providing a vital line of defense against severe respiratory infections.
Researchers at Nagoya University discovered that complement C3 protein acts inside tumors to prevent immunosuppressive cells, improving cancer immunotherapy effectiveness. Higher levels of C3 in tumor tissue were associated with better treatment outcomes and survival rates in patients.
Researchers identified unique antibody signatures against viruses and bacteria in nearly 2,000 blood samples collected over a decade, showing immune system changes years before diagnosis. The study supports the theory of molecular mimicry and provides an important framework for understanding IBD's earliest stages.
Researchers discovered that CRISPR-Cas plays a broader role in bacteria, directing a network of innate immune systems. Over 20 innate defense modules are genomically embedded within type I CRISPR-Cas loci, which are kept under tight transcriptional control by small RNAs.
Scientists at UVA have developed a new method to target glioblastoma, the most common and deadly brain cancer, by delivering microRNAs through the brain's natural barrier. The approach shows promise in slowing tumor growth and extending survival in animal models.
Researchers at UIC identified KCNMB1, an ion channel protein that helps regulate cell movement. Activating this pathway increases cell stiffness, making cancerous cells more susceptible to immune attack. The discovery points to a promising new therapeutic target for metastatic cancer.
Researchers found that sea anemones can selectively distinguish between beneficial and harmful bacteria thanks to 'nematosomes'. This ability is crucial for maintaining a stable microbiome. The study suggests that invertebrates may have sophisticated mechanisms for supporting beneficial microorganisms.
The University of Minnesota Medical School research team has received a $10 million NIH grant to study how animals fight infection. The team will utilize a 'cellular zoo' of living cells from over 100 animal species to understand how different species recognize and respond to viral infections.
Researchers from 12 countries have launched a global effort to document and study 'heritage' diets before they are lost. These diets, shaped by local environments and traditions, may hold vital clues to better health.
Dr. Rui Yang receives a Burroughs Wellcome Fund Career Award for Medical Scientists to uncover genetic causes of life-threatening immune disorders and identify new treatment paths. The research aims to advance diagnosis and understanding of rare diseases while fostering the next generation of scientists.
Scientists at MD Anderson Cancer Center have identified a previously unknown mechanism by which T cells attack and eliminate acute myeloid leukemia (AML) cells. The discovery reveals that AML cells use a CD64-dependent pathway to evade traditional MHC recognition, potentially explaining why AML is sensitive to immune-based treatments.
A buildup of bile acids caused by an unhealthy gut can drive breast cancer to other parts of the body, researchers reveal. The study found that replenishing beneficial bacteria or treating patients with FDA-approved bile acid sequestrants may reduce breast cancer metastasis.
A new study reveals that macrophages, a key immune cell type, age differently across tissues and between sexes. The researchers found that aging macrophages become more focused on responding to stress and cellular damage, but lose some molecular programs involved in maintaining healthy tissue structure.
Macrophages are critical drivers of chronic allograft failure, with emerging strategies targeting key macrophage signaling pathways providing an important conceptual shift. Targeted therapies, such as inhibiting the purinergic pathway and mTOR/NF-κB pathway, show promise in preventing chronic rejection.
Researchers found that yeast-based supplements can reprogram early-stage immune cells to produce enhanced anti-tumor responses. The study suggests a potential solution for obesity-related immune dysfunction and cancer, using a food-grade supplement with an excellent safety record.
A new method called ATTACH identifies strong interactions between T cells and cancer-specific proteins to isolate effective tumor-reactive T cells. This approach overcomes key challenges in immunotherapy development, offering a rapid and accessible way for isolating rare immune cells.
The new journal features cutting-edge research across basic, clinical, and translational immunology. It is designed to connect researchers across the full breadth of immunology, deepening understanding of the immune system in health and disease.
Researchers found that macrophages and monocytes in the gut mesentery interact to prevent salmonella from spreading. Removing macrophages allows monocytes to flood the organ, highlighting the role of these immune cells in regulating tissue damage.
Scientists at La Jolla Institute for Immunology and Scripps Research have developed an HIV vaccine that trains immune cells to see past HIV's defenses. The vaccine resulted in the best HIV-fighting antibody response ever seen in primates, with human trials now underway.
Researchers found that wood frogs' adaptation to salty water increases their vulnerability to ranavirus, a common and fatal disease. The study highlights the hidden costs of survival in wildlife under environmental stress.
A UMD-led study reveals that wild bats balance different types of immune defenses based on sex, age, and competition for mates. The researchers found that male bats rely more on rapid-response immune defenses, while females invest in targeted responses to pathogens.
Researchers present a roadmap for developing Tregs as adaptable therapies to restore immune balance and support tissue repair. This approach holds promise for treating conditions such as metabolic and cardiovascular disease, as well as neurodegeneration.
New therapies using regulatory T cells, known as Tregs, could target diseases with inflammation, such as cancer and autoimmune conditions. Early evaluations show good tolerance and safety profiles, but precision is key to tailoring treatments for specific patients.